Dillard's is a stock, but its analyst coverage is unusually thin. Three firms maintain current 12-month price targets: UBS (Sell, $468), J.P. Morgan (Sell, $519), and Telsey Advisory Group (Hold, $650). The arithmetic mean is about $546, with a range of $468 to $650. Because every one of these targets sits at or below the stock's recent trading price near $600, no meaningful above-price consensus exists, and the minimum-distance rule cannot be satisfied with analyst data.
For that reason, the $700 figure used here is not an analyst price target. It reflects a publicly discussed technical objective: a round-number, psychological resistance level that sits just beneath the stock's 52-week high of $741.98 and near the roughly $695 area where DDS traded in late October. It is a reference point, not a prediction.
With the stock near $602 in early November 2026, moving to $700 would represent roughly 16% upside. On a strict percentage basis, that is a substantial move rather than a modest drift. The company's fundamentals are a study in contrast: DDS remains highly profitable, with trailing EPS (earnings per share) near $43 and a trailing P/E (price-to-earnings) ratio in the mid-teens, yet revenue has contracted for multiple fiscal years, from about $6.87 billion to roughly $6.6 billion.
A path toward $700 would likely require the stock to reclaim and hold prior breakout zones in the upper $600s before challenging the 52-week high. That, in turn, would depend on evidence that the company can stabilize sales and defend margins, which have moderated from prior peaks.
The 52-week range of $503.06 to $741.98 frames the picture. The $700 area acts as psychological resistance just under the $742 high, while support sits near the $600 round number and the mid-$500s zone. A durable move toward $700 would first require clearing the upper-$600s supply zone that has capped rallies; failure to hold $600 could shift focus back toward the $503 low.
Analyst targets typically reflect a roughly 12-month horizon, and the three DDS targets are no exception, though they diverge widely—from $468 to $650—reflecting disagreement over whether the company can defend its profitability as sales decline. Investors should watch the fiscal third-quarter earnings report due in early-to-mid November, guidance on comparable-store sales and margins, any revisions from the three covering firms, and broader consumer-spending data and rate decisions that influence discretionary retail.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly covered name like Dillard's, such tools can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening. Traders seeking an additional, data-driven perspective on daily positioning may want to explore these signals alongside traditional research.
Can Dillard's (DDS) stock reach $700? The question is best answered with context, not certainty. The $700 level is a technical and psychological objective—not a published analyst consensus—and reaching it from around $602 would require a substantial move of roughly 16%. Supporting the case are Dillard's remarkable profitability, strong balance sheet, and recent earnings beat, while the case against rests on persistent revenue declines, moderating margins, and a broadly bearish analyst stance. With three analysts holding targets at or below the current price and a wide $468-to-$650 range, conviction is clearly limited. The most important near-term catalysts are the upcoming earnings report and any shifts in sales trends or analyst revisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, DDS has been loosely correlated with M. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if DDS jumps, then M could also see price increases.
| Ticker / NAME | Correlation To DDS | 1D Price Change % | ||
|---|---|---|---|---|
| DDS | 100% | -3.14% | ||
| M - DDS | 55% Loosely correlated | -2.09% | ||
| KSS - DDS | 51% Loosely correlated | -4.67% | ||
| DDT - DDS | 15% Poorly correlated | +0.39% | ||
| PLBL - DDS | 0% Poorly correlated | +28.79% |